Can-Fite BioPharma's total assets for Q4 2023 were $9.99M, an increase of 7.61% from the previous quarter. CANF total liabilities were $3.75M for the fiscal quarter, a -22.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.